S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q2 2023

RA Capital Management

Period: Q2 2023 Β· Filed: 2023-08-14
View on SEC EDGAR β†—
AUM
$5.30B
Total portfolio value
Positions
54
Reported securities
Top Holding
ASND
18.9% $1.00B
QoQ Changes
+4 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S$1.00B18.92%$89.25$274.50+207.6%
18.9%
LEGNLEGEND BIOTECH CORP$432.4M8.16%$69.03$29.91-56.7%
8.2%
PCVXVAXCYTE INC$394.1M7.44%$49.94$58.39+16.9%
7.4%
DICEDICE THERAPEUTICS INC$365.0M6.89%β€”β€”
6.9%
ETNB89BIO INC$216.3M4.08%β€”β€”
4.1%
BIIBBIOGEN INC$151.8M2.87%$284.85$216.12-24.1%
2.9%
AVTEAEROVATE THERAPEUTICS INC$141.7M2.68%β€”β€”
2.7%
VRNAVERONA PHARMA PLC$133.6M2.52%β€”β€”
2.5%
CVACCUREVAC N V$127.6M2.41%β€”β€”
2.4%
TYRATYRA BIOSCIENCES INC$123.2M2.33%$17.03$30.62+79.8%
2.3%
NAMSNEWAMSTERDAM PHARMA COMPANY$107.0M2.02%$11.89$34.83+192.9%
2.0%
CTKBCYTEK BIOSCIENCES INC$105.0M1.98%$8.54$4.59-46.3%
2.0%
JANXJANUX THERAPEUTICS INC$102.9M1.94%$11.87$15.54+30.9%
1.9%
GERNGERON CORP$101.3M1.91%$3.21$1.36-57.6%
1.9%
INBXINHIBRX INC$100.0M1.89%β€”$97.58
1.9%
RYTMRHYTHM PHARMACEUTICALS INC$93.6M1.77%$16.49$114.17+592.4%
1.8%
DAWNDAY ONE BIOPHARMACEUTICALS I$93.3M1.76%β€”β€”
1.8%
RXSTRXSIGHT INC$87.9M1.66%$28.80$5.61-80.5%
1.7%
COGTCOGENT COMMUNICATIONS HLDGS$76.0M1.43%$11.84$38.69+226.8%
1.4%
PEPGPEPGEN INC$72.7M1.37%$8.94$1.76-80.3%
1.4%
AXSMAXSOME THERAPEUTICS INC$71.9M1.36%$71.86$244.31+240.0%
1.4%
RNAMAVIDITY BIOSCIENCES INC$71.2M1.34%β€”β€”
1.3%
VORXXXXVOR BIOPHARMA INC$70.3M1.33%β€”β€”
1.3%
GHRSGH RESEARCH PLC$66.3M1.25%$11.86$27.01+127.7%
1.3%
WVEWAVE LIFE SCIENCES LTD$62.6M1.18%$3.64$6.26+72.0%
1.2%
ACRVACRIVON THERAPEUTICS INC$62.3M1.18%$12.96$1.72-86.7%
1.2%
ICVXICOSAVAX INC$59.2M1.12%β€”β€”
1.1%
ITOSITEOS THERAPEUTICS INC$58.5M1.10%β€”β€”
1.1%
FDMT4D MOLECULAR THERAPEUTICS IN$55.5M1.05%$18.07$13.00-28.1%
1.1%
MLYSMINERALYS THERAPEUTICS INC$54.2M1.02%$17.05$27.69+62.4%
1.0%

Quarter-on-Quarter Activity

Q2 2023 vs. Q1 2023

New Positions (4)

TickerIssuerNotionalSince Filing
AXSMAXSOME THERAPEUTICS INC$71.9M+240.0%
FDMT4D MOLECULAR THERAPEUTICS IN$55.5M-28.1%
IGMSIGM BIOSCIENCES INC$8.7M
TALSTALARIS THERAPEUTICS INC$7.1M

Exited Positions (8)

TickerIssuerNotional
BLUBELLUS HEALTH INC NEW$91.0M
CLDXCELLDEX THERAPEUTICS INC NEW$62.4M
HLVXHILLEVAX INC$29.1M
KNTEKINNATE BIOPHARMA INC$26.6M
RCKTROCKET PHARMACEUTICALS INC$19.4M
WHWKAADI BIOSCIENCE INC$4.3M
STSASATSUMA PHARMACEUTICALS INC$4.1M
FUSNFUSION PHARMACEUTICALS INC$2.5M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
LEGNLEGEND BIOTECH CORP$315.0M+157.1%-56.7%
NAMSNEWAMSTERDAM PHARMA COMPANY$54.0M+125.0%+192.9%
ASNDASCENDIS PHARMA A/S$255.9M+61.3%+207.6%
BDTXBLACK DIAMOND THERAPEUTICS I$12.9M+36.1%
DAWNDAY ONE BIOPHARMACEUTICALS I$-0.9M+10.9%
PCVXVAXCYTE INC$120.8M+8.2%+16.9%
COGTCOGENT COMMUNICATIONS HLDGS$11.2M+6.9%+226.8%
RYTMRHYTHM PHARMACEUTICALS INC$-4.8M+2.9%+592.4%

Trimmed (3)

TickerIssuerNotionalShares Ξ”Since Filing
IMGNIMMUNOGEN INC$-40.0M-89.3%
NSTGQNANOSTRING TECHNOLOGIES$-17.4M-29.9%
CTKBCYTEK BIOSCIENCES INC$-17.9M-8.1%-46.3%
← Back to Hedge Funds